| All HIV-exposed infants at health unitb | Study participants |  | ||
---|---|---|---|---|---|
 | Infants HIV tested/ live birth (%) | Infants HIV tested / live birth, n (%) | Infants HIV tested/ live birtha n (%) | HIV positive infants, n (%) | Proportional difference in infant HIV testing between study participants and All exposed infants at the hospital |
Site | (Baseline) | (Post intervention) | (Post intervention) | Â | % (P-value) |
Mengo | 304/374 (81.2) | 439/442 (99.3) | 73/75 (97.3) | 2/75 (2.7) | -2.0 (P = 0.106) |
Rubaga | 374/506 (73.9) | 437/540 (80.9) | 71/74 (95.9) | 2/74 (2.7) | 15.0 (P = 0.001) |
Mulago | 1055/2411 (43.7) | 1179/2178 (54.1) | 269/327 (82.3) | 8/327 (2.4) | 28.2 (P < 0.001) |
Mpigi | 81/96 (84.4) | 83/87 (95.4) | 28/35 (80.0) | 1 /35 (2.9) | -15.4 (P = 0.007) |
Total | 1814/3387 (53.6) | 2138/3247 (65.8) | 441/511 (86.3) | 13 /511 (2.5) | 20.5 (P < 0.001) |